These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9741687)

  • 21. Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications.
    Watts GF; Cummings MH; Umpleby M; Quiney JR; Naoumova R; Thompson GR; Sönksen PH
    Eur J Clin Invest; 1995 Aug; 25(8):559-67. PubMed ID: 7589011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
    Hooper AJ; Heeks L; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PH; van Bockxmeer FM; Burnett JR
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition.
    Elam MB; von Wronski MA; Cagen L; Thorngate F; Kumar P; Heimberg M; Wilcox HG
    Lipids; 1999 Aug; 34(8):809-16. PubMed ID: 10529091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between free fatty acid concentrations and triglyceride-rich lipoproteins in the post-prandial state is altered by a common deletion polymorphism of the apo B signal peptide.
    Byrne CD; Wareham NJ; Mistry PK; Phillips DI; Martensz ND; Halsall D; Talmud PJ; Humphries SE; Hales CN
    Atherosclerosis; 1996 Nov; 127(1):35-42. PubMed ID: 9006802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity.
    Chan DC; Watts GF; Barrett PH; Mori TA; Beilin LJ; Redgrave TG
    J Clin Endocrinol Metab; 2002 May; 87(5):2283-9. PubMed ID: 11994377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of intraperitoneal and posterior subcutaneous abdominal adipose tissue compartments as predictors of VLDL apolipoprotein B-100 kinetics in overweight/obese men.
    Chan DC; Watts GF; Barrett PH
    Diabetes Obes Metab; 2003 May; 5(3):202-6. PubMed ID: 12681028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of apolipoprotein E genotype on apolipoprotein B-100 metabolism in normolipidemic and hyperlipidemic subjects.
    Ooi EM; Janus ED; Grant SJ; Sinclair LM; R Barrett PH
    J Lipid Res; 2010 Aug; 51(8):2413-21. PubMed ID: 20413671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in obesity: a stable isotope study.
    Cummings MH; Watts GF; Pal C; Umpleby M; Hennessy TR; Naoumova R; Sönksen PH
    Clin Sci (Lond); 1995 Feb; 88(2):225-33. PubMed ID: 7720348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100.
    Li X; Grundy SM; Patel SB
    J Lipid Res; 1997 Jul; 38(7):1277-88. PubMed ID: 9254055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased frequency of apolipoprotein B signal peptide sp24/24 in patients with coronary artery disease. General allele survey in the population of Taiwan and comparison with Caucasians.
    Wu JH; Wen MS; Lo SK; Chern MS
    Clin Genet; 1994 May; 45(5):250-4. PubMed ID: 8076410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity.
    Chan DC; Watts GF; Gan S; Wong AT; Ooi EM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1043-50. PubMed ID: 20150556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of diet and serotonergic agonist on hepatic apolipoprotein B-100 secretion and endothelial function in obese men.
    Watts GF; Herrmann S; Riches FM
    QJM; 2000 Mar; 93(3):153-61. PubMed ID: 10751234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men.
    Evans AE; Zhang W; Moreel JF; Bard JM; Ricard S; Poirier O; Tiret L; Fruchart JC; Cambien F
    Hum Genet; 1993 Sep; 92(2):191-7. PubMed ID: 8370587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency.
    Ikewaki K; Cain W; Thomas F; Shamburek R; Zech LA; Usher D; Brewer HB; Rader DJ
    J Lipid Res; 2004 Jul; 45(7):1302-11. PubMed ID: 15102883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE; Barrett PH; Demant T; Parhofer KG
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48- relative to B-100-containing lipoproteins.
    Li X; Catalina F; Grundy SM; Patel S
    J Lipid Res; 1996 Jan; 37(1):210-20. PubMed ID: 8820116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Ordovas JM; Schaefer EJ
    J Lipid Res; 1997 Aug; 38(8):1535-43. PubMed ID: 9300775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice.
    Maugeais C; Tietge UJ; Tsukamoto K; Glick JM; Rader DJ
    J Lipid Res; 2000 Oct; 41(10):1673-9. PubMed ID: 11013310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.